Fig. 9.
Fig. 9. Survival following vaccination with BCL1 Id adenovirus versus BCL1 Id-KLH protein. / Groups of 10 BALB/c mice were given a single IM injection of 108 PFU Ad-BCL1huCR (▴) or 38C13 virus Ad-IdhuCR (▵) versus 2 biweekly SQ injections of PBS (○) or BCL1 Id-KLH protein (BCL1-KLH) plus QS21 adjuvant (▪). Three weeks later, mice were injected IP with 5 × 104 BCL1 tumor cells and followed for survival. Results are representative of 2 individual experiments.

Survival following vaccination with BCL1 Id adenovirus versus BCL1 Id-KLH protein.

Groups of 10 BALB/c mice were given a single IM injection of 108 PFU Ad-BCL1huCR (▴) or 38C13 virus Ad-IdhuCR (▵) versus 2 biweekly SQ injections of PBS (○) or BCL1 Id-KLH protein (BCL1-KLH) plus QS21 adjuvant (▪). Three weeks later, mice were injected IP with 5 × 104 BCL1 tumor cells and followed for survival. Results are representative of 2 individual experiments.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal